Search
for
Sort by
Research 61–90 of 288
- Redefining hormone resistance in prostate cancer
- Human TSC2-null fibroblast-like cells induce hair follicle neogenesis and hamartoma morphogenesis
- Pathogenesis and treatment options for chemotherapy‐induced alopecia: a systematic review
- Characterisation of cell cycle arrest and terminal differentiation in a maximally proliferative human epithelial tissue: Lessons from the human hair follicle matrix
- Fatigue, alopecia and stomatitis among patients with breast cancer receiving cyclin-dependent kinase 4 and 6 inhibitors: a systematic review and meta-analysis
- Applications and Risks of Nanomaterials Used in Regenerative Medicine, Delivery Systems, Theranostics, and Therapy
- Safety of 5α-reductase inhibitors and spironolactone in breast cancer patients receiving endocrine therapies
- Persistent major alopecia following adjuvant docetaxel for breast cancer: incidence, characteristics, and prevention with scalp cooling
- Molecular pathology of skin adnexal tumours
- Clinical-exome sequencing unveils the genetic landscape of polycystic ovarian syndrome (PCOS) focusing on lean and obese phenotypes: implications for cost-effective diagnosis and personalized treatment
- Androgen Receptor in Human Health: A Potential Therapeutic Target
- Use of a Healthcare Claims Database for Post-Marketing Safety Assessments of Eribulin in Japan: A Comparative Assessment with a Prospective Post-Marketing Surveillance Study
- Progress in Relevant Growth Factors Promoting the Growth of Hair Follicle
- A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metastatic salivary duct carcinoma – the DUCT study protocol
- Dermatologic adverse events associated with chemotherapy and targeted anticancer therapy
- Cutaneous Drug Eruptions Associated with the Use of Biologies and Cutaneous Drug Eruptions Mimicking Specific Skin Diseases
- Purified Vitexin Compound 1 Inhibits UVA-Induced Cellular Senescence in Human Dermal Fibroblasts by Binding Mitogen-Activated Protein Kinase 1
- Evaluation of dermatologic adverse events associated with aromatase inhibitors: insights from the FAERS database
- A Comprehensive Review on Current and Future Trends of Nanoemulsions in Modern Cosmetics and Pharmaceuticals
- Management of Toxicities of Targeted Therapies
- Chemotherapy-Induced Alopecia
- Ether: Fiction or Reality? A Review
- МИКРОБИОЦЕНОЗ ЛУНОК УДАЛЕННЫХ ЗУБОВ У ПАЦИЕНТОВ С АЛЬВЕОЛИТОМ
- Adverse Hair Reactions to New Targeted Therapies for Cancer
- Cutaneous drug reactions
- Efficacy and tolerability of scalp cooling in preventing alopecia during (neo)adjuvant chemotherapy for breast cancer
- Cutaneous gain-of-function mutation of LRIG3 leads to alopecia by upregulation of ERBB, PI3K/AKT, NOTCH1 signaling pathways
- Novel drugs of United States Food and Drug Administration approved in 2024
- The pharmacovigilance analysis of adverse events of erlotinib based on the open access FAERS database
- Sacituzumab tirumotecan (sac-TMT/MK-2870/SKB264): a novel antibody–drug conjugate in breast cancer